Last reviewed: June 26, 2026
Last updated: June 26, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Ozempic and Wegovy, is FDA-approved for treating both type 2 diabetes and chronic weight management in adults with obesity. The same medication addresses two different health conditions because it works through a single biological pathway—the glucagon-like peptide-1 (GLP-1) receptor—that influences blood sugar control, appetite regulation, and metabolic rate.
How Semaglutide Works for Diabetes and Weight Loss
Semaglutide activates GLP-1 receptors located throughout the brain, pancreas, and digestive tract. In the pancreas, it stimulates insulin release when blood glucose rises, helping lower blood sugar in people with type 2 diabetes. In the brain, it signals satiety centers that reduce hunger and increase feelings of fullness—the mechanism behind weight loss.
Clinical trials show semaglutide reduces hemoglobin A1C (a marker of long-term blood sugar control) by up to 2 percentage points in diabetic patients. The same trials demonstrate 10-22% body weight reduction in individuals without diabetes who received higher doses. This dual benefit occurs because one medication targets multiple organs and systems that both regulate glucose and control appetite.
Key Differences Between Ozempic and Wegovy Dosing
Ozempic is prescribed for type 2 diabetes at starting doses of 0.25 mg weekly, typically titrated to 1 mg weekly. Wegovy, the weight-loss version, follows a similar titration schedule but reaches 2.4 mg weekly for obesity treatment. Both contain identical semaglutide, but marketing and indication differ based on the condition being treated and the target dose range.
PlexusDx provides compounded semaglutide injection with personalized dosing protocols based on your metabolic profile and health goals. Your dose may need to go up as your body adapts, but your price stays flat at $149 monthly across all dose levels—ensuring affordability regardless of where your treatment progresses.
Semaglutide Effectiveness Data for Weight Loss
The STEP trials (Semaglutide Treatment Effect in People with obesity) enrolled over 4,500 participants and measured weight loss over 68 weeks. Participants receiving 2.4 mg weekly semaglutide lost an average of 94 pounds, compared to 11 pounds in the placebo group. This represents approximately 15% of baseline body weight—a clinically significant reduction that improves metabolic health, mobility, and disease risk.
For people with type 2 diabetes, the SUSTAIN trials showed semaglutide reduced body weight by 3-6 kg at lower doses (0.5-1.0 mg weekly) while simultaneously improving blood sugar control. Many diabetes patients experience dual benefits: better glucose management and modest weight loss, which further improves insulin sensitivity and reduces medication burden.
Personalized Treatment: The PlexusDx Precision Peptide Genetic Test
Not everyone responds identically to semaglutide. Your genetic profile influences how efficiently your body uses GLP-1 signaling pathways and how strongly you experience appetite suppression. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 49 peptides across 14 metabolic pathways, including key variants in the GLP1R gene (rs6923761), the GIPR gene (rs1800437), the FTO gene (rs9939609), and the MC4R gene (rs17782313).
These genetic insights reveal whether you have high, moderate, or low predicted responsiveness to GLP-1 therapy and help inform optimal dosing strategies. Patients with certain genetic variants may benefit from faster titration or combination peptide therapies (such as tirzepatide, which also activates the GIP receptor). PlexusDx uses your test results to refine your personalized treatment plan within weeks of starting therapy.
Cost and Access: No Insurance Required
PlexusDx compounded semaglutide injection starts at $149 per month and is available in all 50 states without insurance, membership fees, or prior authorization delays. The medication is prepared by licensed 503A compounding pharmacies and is HSA/FSA eligible, allowing you to use tax-advantaged health savings accounts to pay. Rapid shipping and discreet packaging ensure privacy and convenience.
If you prefer oral semaglutide, PlexusDx offers that option at $249 monthly. Both injection and oral forms deliver the same active ingredient with identical clinical efficacy—the choice depends on your comfort with self-injection and personal preference. Treatment begins within days of your initial consultation, not weeks.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is semaglutide only for diabetes or weight loss?
Semaglutide treats both conditions through the same biological mechanism. When prescribed for type 2 diabetes (Ozempic), it improves blood sugar control and often produces weight loss as a secondary benefit. When prescribed for obesity (Wegovy), it reduces appetite and body weight while also improving glucose metabolism. PlexusDx compounded semaglutide injection ($149/mo) serves patients with either condition or both.
How much weight do people typically lose on semaglutide?
In STEP clinical trials, participants on 2.4 mg weekly semaglutide lost an average of 94 pounds over 68 weeks (approximately 15% of body weight). Results vary based on genetics, lifestyle, and adherence. The PlexusDx Precision Peptide Genetic Test can predict your likely responsiveness category before you start treatment, helping set realistic expectations.
Can I start semaglutide without a diabetes diagnosis?
Yes. Semaglutide is FDA-approved for weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related health conditions. You do not need diabetes to qualify. PlexusDx serves all 50 states and evaluates each patient individually during your consultation to ensure semaglutide aligns with your health goals.
Does the price change if my dose increases?
No. PlexusDx compounded semaglutide injection maintains a flat price of $149 per month regardless of dose level. Your dose may need to go up as your body adjusts and tolerates higher amounts—but your price won't. This transparent pricing model removes cost barriers to dose optimization.
What is the Precision Peptide Genetic Test and does it predict my results?
The Precision Peptide Genetic Test ($99 add-on after your first treatment month) analyzes 49 peptides across 14 pathways, including GLP1R, GIPR, FTO, and MC4R variants. It predicts your genetic responsiveness to GLP-1 therapy—whether you are likely a strong, moderate, or lower responder. This guides personalized dosing and helps determine if combination therapy (such as tirzepatide) might optimize your outcomes.
Is compounded semaglutide as safe as brand-name Ozempic or Wegovy?
PlexusDx compounded semaglutide is prepared by licensed 503A compounding pharmacies under strict FDA oversight. Compounded medications meet the same purity, sterility, and potency standards as brand-name equivalents. The active ingredient is identical; the difference is cost and accessibility. Always discuss your medical history with your PlexusDx provider before starting any GLP-1 therapy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Metformin and Ozempic: Do You Still Take Both for Diabetes & Weight Loss?
Does Wegovy Make You Tired? Understanding Fatigue as a Side Effect